Discover more from CovidLawCast.Com
Follow the Money I
This video is so concise, I had to post it. It is worth 20 minutes of your time:
AJ DePriest Uncovers The Enormous Covid Bribes (rumble.com)
The coronavirus relief legislation created a 20% premium, or add-on, for COVID-19 Medicare patients. Have hospitals been exaggerating COVID-19 numbers to receive higher Medicare payments?
Meanwhile, there is s drug that costs pennies available that could have saved hundreds of thousands of lives. 83 Studies found for: ivermectin (IVM) See Search Details
Can ivermectin be used? Yes:
Evolving Knowledge on Treatment for COVID-19 Currently, remdesivir, an antiviral agent, is the only Food and Drug Administration-approved drug for the treatment of COVID-19. An array of drugs approved for other indications and multiple investigational agents are being studied for the treatment of COVID-19 in clinical trials around the globe. These trials can be accessed at ClinicalTrials.gov. In addition, providers can access and prescribe investigational drugs or agents that are approved or licensed for other indications through various mechanisms, including Emergency Use Authorizations (EUAs), Emergency Investigational New Drug (EIND) applications, compassionate use or expanded access programs with drug manufacturers, and/or off-label use. … The choice of what to do or not to do for an individual patient is ultimately decided by the patient and their provider.
Go to page 9 of NIH treatment guidelines, here.
In a descriptive, uncontrolled interventional study of 33 contacts of patients with laboratory-confirmed COVID-19, no cases of SARS-CoV-2 infection were identified within 21 days of initiating ivermectin for PEP. An open-label randomized controlled trial investigated ivermectin prophylaxis (plus personal protective measures [PPMs]) in health care workers (as PrEP) or in household contacts (as PEP) exposed to patients with laboratory-confirmed COVID-19. The incidence of SARS-CoV-2 infection was lower among the participants who received ivermectin than among control participants who used only PPMs. However, the study provided no data on the characteristics of the study participants, types of exposures, or how endpoints were defined. Finally, in a small case-control study in SARS-CoV-2-exposed health care workers, 186 participants who became infected were matched with 186 uninfected controls. Of those who received ivermectin after exposure to SARS-CoV-2, 38 were in the infected group and 77 were in the uninfected group, which led the investigators to conclude that ivermectin reduced the incidence of SARS-CoV-2 infection.
Go to page 29 of NIH treatment guidelines here.
The history of IVM is here. Its good for horses and people too.